Clinical trials: Koebner Phenomenon
Vitiligo
Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)
We will investigate the process of vitiligo induction and the influence of different commonly used cream treatments on this process.
- Trial name
- Koebner (NCT01082393)
- Testing
- topical tacrolimus treatment, topical pimecrolimus treatment, local mometasone furoate treatment
- Where
- Belgium
- Volunteers
- 14 people
- Sponsor
- University Hospital, Ghent
Psoriasis Vulgaris, Koebner Phenomenon
PSODEEP2 Pilot Study on Koebner Induction in Psoriasis
Patients (n=15) with skin psoriasis, minimum age 18 years, without systemic immunomodulatory treatment will be subject to Koebner induction on arms and legs given that they have given written consent and that they have…
- Trial name
- PSODEEP2PIL (NCT06414382)
- Testing
- Tape-stripping
- Volunteers
- 15 people
- Sponsor
- Skane University Hospital
Psoriasis, Psoriasis; Arthritis (Etiology)
The Study of Koebner in Patients With Psoriasis and Psoriatic Arthritis
PSODEEP 1 is a descriptive digital interview study where we intend to include at least 900 individuals. Individuals with known psoriasis or known psoriatic arthritis will access the digital interview via a QR code distributed via…
- Conditions
- Psoriasis, Psoriasis; Arthritis (Etiology), Koebner Phenomenon
- Trial name
- PSODEEP1 (NCT05589298)
- Where
- Sweden
- Volunteers
- 3,064 people
- Sponsor
- Skane University Hospital